MEBO治疗外伤后感染性小面积头皮缺损疗效分析

目的 :观察湿润烧伤膏 (MEBO)与常规换药方法对外伤性感染后小面积头皮缺损的疗效。方法 :将1997～ 1999年收治的 12例感染性头皮缺损病人随机分为两组 ,即MEBO组与常规换药组 ,各 6例。病人均为院外已行缝合术 ,但发生头皮下感染的病例 ,平均皮肤感染的面积为 6 0± 1 3cm2 ,两组伤情相近。MEBO组按烧伤湿性医疗技术操作规程换药治疗 ,常规换药组按传统换药治疗 ,观察创面愈合时间。结果 :MEBO组愈合时间 ( n±S)为 15 0± 2 2天 ,常规换药组为 2 0 2± 2 6天 ,组间相比有非常显著性差异 (P <0 0 1)结论 :湿润烧伤膏对外伤后感染性小面积头皮缺损有较好疗效。     

MEBO治疗溃疡性褥疮临床观察

目的 :应用湿润烧伤膏 (MEBO)治疗溃疡性褥疮 ,观察其疗效。方法 :将 60例病人随机分为MEBO治疗组与庆大霉素治疗对照组 ,分别将MEBO或庆大霉素涂于溃疡创面上 ,每日包扎换药 2次。结果 :两组痊愈率和总有效率有明显差异 (P <0 0 5)。结论 :MEBO治疗溃疡性褥疮疗效满意 ,优于庆大霉素疗法     

深部脓肿切开引流术后的换药治疗

目的:探讨深部脓肿切开引流术后用湿润烧伤膏换药的疗效及机制。方法:将62例深部脓肿切开引流术后患者随机分成两组,比较两组分别用湿润烧伤膏纱条换药和凡士林纱条换药的疗效。结果:湿润烧伤膏组平均治愈时间9．5±2．7d,凡士林组平均治愈时间12．2±3．6d,两者比较有显著差异(P＜0．01)。结论:湿润烧伤膏纱条用于深部脓肿切开引流,术后换药效果好、疗程短,为目前首选药物。     

湿润烧伤膏在中厚皮片供区创面处理中的应用

目的 :探讨湿润烧伤膏 (MEBO)在中厚皮片供皮区创面的治疗效果。方法 :选择 72例因功能部位深度烧伤切痂或瘢痕挛缩畸形整形并行中厚皮片移植术的患者 ,根据皮片供区创面处理方法不同分为传统方法组 (32 )例和湿润烧伤膏组 (4 0例 ) ,对两组创面的愈合时间和感染情况进行比较。结果 :传统方法组愈合时间 10天～ 2 8天 ,平均 17 4± 7 4天 ,6例创面发生感染 ;湿润烧伤膏组愈合时 9天～ 17天 ,平均 12 2± 4 2 ,仅 1例创面出现脓疱。两组间平均愈合时间比较P <0 0 1。结论 :在适当时机应用湿润烧伤膏治疗中厚皮片供皮区创面 ,可明显细胞短愈合时间 ,并减轻病人痛苦     

湿润烧伤膏治疗老年糖尿病褥疮22例观察

目的 :探讨湿润烧伤膏 (MEBO)治疗老年糖尿病褥疮的有效性 ,寻找理想的治疗方面。方法 :将 4 4例Ⅱ期 ,Ⅲ期 ,Ⅳ期褥疮患者随机分为观察组 (MEBO组 )和对照组各 2 2例 ,MEBO组以MEBO治疗 ,对照组采用创面冲洗 ,庆大霉素与胰岛素敷料包扎结合TDP辐射创面治疗。结果 :MEBO组总有效率 10 0 % ,30天治愈率明显高于对照组 (x2 =4 4 9,p <0 0 5 ) ;平均痊愈时间为 13 4 6± 2 70天 ,明显短于对照组的 18 87± 2 94天 (t=6 36 ,p <0 0 0 1)。结论 :MEBO治疗老年糖尿病褥疮疗效显著 ,方法简便 ,值得推广应用。     

湿润烧伤膏联合美宝创疡贴与单纯使用湿润烧伤膏治疗Ⅲ期压疮疗效对比分析

目的:探讨湿润烧伤膏联合创疡贴治疗Ⅲ期压疮较单纯使用湿润烧伤膏的优势.方法:选取我院我科病例52例,其中对照组单纯使用湿润烧伤膏病例26例,实验组湿润烧伤膏联合创疡贴26例,对比两组治疗效果,主要观察指标为愈合时间、换药次数、治疗费用.结果:实验组平均愈合时间为35.31天±3.62天,对照组平均愈合时间为46.45天±3.83天;实验组平均换药次数为55.94次±8.15次,对照组平均换药次数为77.30次±10.51次;实验组较对照组治疗费用降低.结论:湿润烧伤膏联合创疡贴治疗Ⅲ期压疮较单纯使用湿润烧伤膏愈合更快,换药次数更少,费用更低.     

湿润烧伤膏治疗腋臭术后切口愈合不良的疗效体会

目的观察湿润烧伤膏治疗腋臭术后切口愈合不良的疗效。方法将汕头市中心医院2010年1月-2014年6月收治的22例(31处)腋臭术后切口愈合不良患者随机分为湿润烧伤膏组(16处)和碘伏组(15处),湿润烧伤膏组患者采用外科清创联合湿润烧伤膏换药治疗,每日1次;碘伏组患者采用外科清创联合碘伏纱布包扎换药治疗,每日1次,对比观察两组患者换药时的疼痛情况及切口愈合时间。结果湿润烧伤膏组患者的切口平均愈合时间为7.375 d±1.586 d,碘伏组患者的切口平均愈合时间为9.267 d±1.624 d,两组对比,P=0.003,差异具有统计学意义;湿润烧伤膏组患者换药时有9例无疼痛、7例轻微疼痛,碘伏组患者换药时有2例无疼痛、12例轻微疼痛、1例中度疼痛,两组对比,P=0.02,差异具有统计学意义。结论湿润烧伤膏对腋臭术后切口愈合不良的疗效显著,换药时的疼痛程度及创面愈合时间均优于碘伏组,值得临床推广应用。     

湿润烧伤膏治疗Ⅱ期褥疮临床疗效观察

目的：观察湿润烧伤膏(MEBO)治疗Ⅱ期褥疮的效果。方法：将36例病人随机分治疗组(创面敷湿润烧伤膏)和对照组(按传统方法包扎)，观察褥疮病灶的治愈率和创面结痂时间。结果：治疗组的治愈率明显优于对照组，治疗组的创面结痂时间短于对照组，且具有统计学意义。结论：湿润烧伤膏治疗Ⅱ期褥疮能提高褥疮的治愈率，缩短创面结痂时间。     

CO2激光照射联合湿润烧伤膏治疗睑黄瘤的临床观察

目的:探讨CO2激光照射与湿润烧伤膏联合治疗睑黄瘤的疗效.方法:64例病变先运用CO2激光气化治疗,根据照射创面处理方法分为两组:湿润烧伤膏组:烧灼后创面外涂湿润烧伤膏;传统组:创面采用外科换药法治疗(外用0.5%碘伏),观察它们的创面愈合时间、创面恢复后的外观形态等.结果:湿润烧伤膏组创面平均愈合时间7.8天±1天,外观理想;传统组创面平均愈合时间13.0天±1.5天,15例29处创面出现扁平瘢痕.结论:CO2激光照射与湿润烧伤膏联合治疗睑黄瘤疗效肯定,使用方便.     

阴茎深Ⅱ度烧伤创面临床疗效对比观察

目的 :探讨湿润烧伤膏 (MEBO)治疗阴茎深Ⅱ度烧伤创面的近期临床疗效。方法 :对 1996年 4月～2 0 0 3年 3月期间 ,采用MEBO治疗的 37例阴茎深Ⅱ度烧伤 ,与同期采用磺胺嘧啶银 (SD -Ag)霜治疗的 2 3例阴茎深Ⅱ度烧伤创面的近期疗效进行比较分析。结果 :MEBO治疗组深Ⅱ度烧伤创面的愈合时间为 19 7天± 2 1天 ,SD Ag霜治疗组为 2 3 4天± 4 4天 ,组间比较P <0 0 5。结论 :湿润烧伤膏可促进阴茎深Ⅱ度烧伤创面愈合 ,近期疗效优于磺胺嘧啶银霜疗法     

Dealing with cancer--conversations with radiotherapy patients

Thirty in-patients treated by radiotherapy were questioned in qualitative interviews about the information they had received from the physicians and their way to deal with the disease and the physicians. Furthermore 18 persons out of this group were accompanied continuously. The confidential relationships between the patients and the author of the study brought about spontaneous conversations showing some new aspects of the way to experience disease and therapy. Despite a poor prognosis and an initially insufficient information, the patients formulated their questions openly. Generally they desired a clearer communication. They criticized above all the lack of information and attention from the physicians. A need for confidence, frankness, and the conveyance of a justified hope was expressed. The physician's stress and resulting lack of time was complained of. During the time of accompanying which lasted several weeks, it became evident that information means a way to deal with the disease to which the patient can make his individual contribution. The majority of questions as well as emotional reactions as fear or depression came from those patients who seemed to be quiet persons.     

Radiochemotherapy with temozolomide for patients with glioblastoma

Background

The objective of this retrospective analysis was to assess long-term outcome and prognostic factors of unselected patients treated for glioblastoma (GB) at a single center with surgery, standard radiotherapy (RT), and concomitant temozolomide (TMZ). From 1999?C2005, the institutional protocol included surgery and RT with TMZ. From 2005 on, adjuvant TMZ was routinely added.

Patients and Methods

Between April 1999 and September 2009, 181 patients with GB were treated with RT (60 Gy in 30 fractions) and concomitant TMZ (75 mg/m²/day throughout RT). Biopsy only had been performed in 53 patients (29.3%), 128 patients (70.7%) had undergone resection, which was complete based on postoperative MRI in 51 patients (28.2%). Adjuvant TMZ was applied in 67 of 181 patients (37%).

Results

Median overall survival (OS) and progression-free survival (PFS) were 15.0 (95% CI, 13.1?C16.8) and 7.2 months (95% CI, 5.9?C8.5), respectively. After complete resection, partial/subtotal resection and biopsy, median OS was 23.20, 14.75, and 7.89 months (p < 0.001), respectively. In multivariate Cox proportional hazards regression models, extent of resection (p < 0.0001), Karnofsky??s performance score (p < 0.0001) and adjuvant TMZ (p = 0.001) were significant independent prognostic factors for OS. RT with concomitant TMZ was well tolerated in the majority of patients and could be completed as scheduled in 146 patients (80.7%), while 11 patients (6.1%) discontinued RT. Another 35 patients (19.3%) interrupted concomitant chemotherapy.

Conclusion

RT with concomitant TMZ is a feasible regimen with acceptable toxicity in routine practice. Our data are compatible with a beneficial effect of adjuvant TMZ on OS and PFS.     

MEBO药纱门诊治疗烧(烫)伤71例的体会

作者报道用MEBO药纱敷盖门诊治疗烧（烫）伤71例，均获治愈。经随访1年，深Ⅱ度创面疤痕发生率为15％（3／20），浅Ⅲ度创面疤痕发生率为38．9％（7／18）。     

Bronchogenic carcinoma: staging with MR compared with staging with CT and surgery

Thirty-three patients suspected of having bronchogenic carcinoma were studied prospectively using magnetic resonance (MR). In this group, 30 underwent examination with computed tomography (CT), 15 underwent thoracotomy, six had mediastinal biopsy procedures performed, and eight underwent bronchoscopy. MR studies, which included transaxial spin-echo imaging (TR, 0.5 and 2.0 sec; TE, 28 and 56 msec) of all patients and sagittal or coronal imaging of 18, were performed without knowledge of CT findings, using only plain radiographs as a guide. CT and MR studies were interpreted separately. CT and MR provided comparable information regarding the presence and size of mediastinal lymph nodes. MR better discriminated mediastinal nodes from vascular structures. However, in two of 11 patients who had multiple mediastinal lymph nodes that were normal in size at CT examination and surgery, MR suggested a confluent abnormal mass, probably because of its poorer spatial resolution. MR was superior to CT in showing enlarged hilar lymph nodes, but CT was better for demonstrating bronchial abnormalities. In three of four patients who had a proved hilar mass with distal obstructive pneumonia, MR (TR, 2.0 sec) helped distinguish between the mass and collapsed lung.     

臭氧治疗船员下肢损伤89例

2006年10月至2007年4月,我科采用引进的德国赫尔曼Medozon型臭氧发生装置系统产生的臭氧治疗船员下肢损伤89例,疗效满意.现报告如下.     

Tumor Burden Assessment with Positron Emission Tomography with

Objective: In patients with advanced cancer, total tumor burden affects the likelihood of tumor response and has important implications for prognosis. The aim of this study was to select the optimum 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG PET) tumor uptake parameter to accurately measure tumor burden in advanced metastatic renal cell cancer, in comparison with volumes measured with computed tomography (CT), as a reference test.Materials and Methods: Six patients with metastatic renal cell carcinoma measurable on CT were studied. CT and FDG PET scans were carried out on all patients within 4 weeks prior to their entry into a phase I-II radioimmunotherapy trial. CT-based evaluation of disease extent (tumor volume) and 4 PET-based measurements (standardized uptake value[SUVmax], SUVav, volume, and total lesion glycolysis [TLG]) were performed independently by a radiologist (VN) and a nuclear medicine physician (TA). The degree of correlation between conventional (CT) extent of disease and parameters describing tumor concentration of FDG was then determined.Results: Fifty-seven CT-measurable metastatic lesions in lung, abdomen, and scalp were evaluated in 6 patients. There was a high correlation between CT and FDG PET volume estimates for lesions greater than 5 cm(3) in size. However, a PET-derived parameter that embodies both FDG uptake and lesion size, the TLG, correlated better with CT-derived tumor volume than did FDG PET volume alone.Conclusion: Using CT volume as a gold standard, the optimal PET-based estimate of total tumor burden in patients with metastatic renal cancer is the sum over all lesions of the total lesion glycolysis.     

烧伤合并多器官功能衰竭117例临床分析

目的　探讨烧伤合并多器官功能衰竭 (MOF)的临床特点。方法　对 1993年 1月— 2 0 0 2年 12月治疗的 117例烧伤合并MOF作出分析。结果　吸入性损伤、休克、全身性感染是烧伤后导致MOF的常见诱因 ,烧伤合并MOF后果严重、死亡率极高。结论　抓住休克、感染的预防 ,是减少MOF发生率、降低烧伤死亡率的关键。     

多虑平、雷尼替丁治疗消化性溃疡81例临床观察

1995年 1月～ 1 998年 2月 ,我们采用多虑平、雷尼替丁治疗消化性溃疡 (ＰＵ) ,并与雷尼替丁为对照组进行治疗观察 ,疗效满意 ,现总结报告如下。1　临床资料1 1　一般资料　本组 81例ＰＵ均因上腹痛、返酸、腹胀及食欲不振等症状 ,经胃镜诊断为溃疡活动期患者。病程 2个月～ 5ａ,平均 1 7ａ。伴有焦虑、抑郁及夜眠欠佳等症者59例。随机分为 2组 :治疗组 4 1例 ,男 3 8例 ,女 3例 ;年龄 1 8～ 3 6岁 ,平均 2 4岁。其中胃溃疡 1 1例 ,十二指肠球部溃疡 3 0例。对照组 4 0例 ,男 3 7例 ,女 3例 ;年龄 1 9～ 3 5岁 ,平均 2 4 5岁 ;胃溃疡 1 2…